Teledermatology Mobile Apps



Status:Not yet recruiting
Healthy:No
Age Range:Any
Updated:4/6/2019
Start Date:April 15, 2019
End Date:September 8, 2020
Contact:Dennis H Oh, MD PhD
Email:Dennis.Oh@va.gov
Phone:(415) 750-2091

Use our guide to learn which trials are right for you!

Teledermatology Mobile Apps: Implementation and Impact on Veterans' Access to Dermatology

This study will measure the impact of two teledermatology apps, VA Telederm and MY Telederm,
WITH TWO SEPARATE TRIALS on access to dermatology care. The overall hypothesis is that sites
implementing Department of Veterans Affairs' (VA) teledermatology mobile apps will
significantly augment the use of teledermatology and improve Veterans' access to skin care
relative to control sites. Specifically, the investigators hypothesize that VA Telederm will
facilitate the implementation and adoption of teledermatology among primary care clinic
staff, increasing use by existing programs and potentially expanding teledermatology to new
sites while reducing patient travel to dermatology clinics. Additionally the investigators
hypothesize that My Telederm will improve established patients' ability to follow-up with
dermatology care remotely, while opening up dermatology clinic space for other patients.

Access to healthcare is currently a key priority for the Department of Veterans Affairs (VA).
The current practice of teledermatology in VA is effective but has not been uniformly
implemented, and inefficiencies in the current workstation-based process may discourage
teledermatology adoption by primary care clinics. VA Office of Connected Care developed a
mobile app, VA Telederm, as a more facile and efficient option that may enhance
teledermatology adoption among providers. Once patients establish care in a dermatology
clinic, they often need follow-up visits to evaluate responses to treatment and to adjust
management, neither of which necessarily requires a face-to-face visit. To address these
issues, OCC has additionally developed the My Telederm app to allow established dermatology
clinic patients to follow-up in person, the app may improve clinic access to in-person
dermatology clinics. The mobile apps are thus new programs that are planned for wide-spread
implementation in the VA. The investigators will conduct TWO SEPARATE TRIALS of database
reviews to understand how these two apps affect features of dermatology care, specifically
related to access to care.

Both apps will be made available over a 2 year period in a randomized, stepped-wedge design
to Veterans Health Administration (VHA) facilities. The VA Telederm app will be distributed
to 36 eligible VHA facilities that currently have low teledermatology activity and thus have
had relatively poor adoption of basic consultative teledermatology. The My Telederm app will
be distributed to 24 facilities with dermatology clinics that currently have relatively high
teledermatology activity and thus already have relatively mature teledermatology programs
ready for advanced operations.

By using health factors and stop codes unique to each app, the investigators will use the VA
Corporate Data Warehouse (CDW) to measure the impact of both apps in two separate trials on
outcomes reflecting dermatology access. At the end of the study period, the proposed research
will result in a novel documentation of mobile teledermatology's effectiveness in enhancing
Veteran's access to dermatology service. The results will be of significance to VA as it
develops and implements other mobile telehealth programs, and more generally to other
healthcare organizations planning for large-scale telehealth interventions.

Inclusion Criteria:

- For the VA telederm trial, teledermatology at a site constituted a minimum of 0.1% and
less than 8.8% of all FY2016 dermatology encounters under secondary stop codes 695/696
(teledermatology readings).

- In total the investigators identified 36 sites eligible for VA Telederm.

- Conversely, the inclusion criterion for the second trial with My Telederm was that a
site had greater than or equal to 8.8% of all FY2016 dermatology encounters under
secondary stop codes 695/696.

- This indicated considerable pre-existing experience with consultative teledermatology
and the likely presence of dermatology reader and support personnel needed to
implement My Telederm.

- The investigators identified 24 sites eligible for My Telederm.

Exclusion Criteria:

- VA medical centers with no 695/696 stop code activity in FY2016 or with zero full-time
equivalent dermatologists were excluded since these sites likely lack the expertise,
support, and infrastructure to feasibly adopt teledermatology during the study period.

- The investigators also excluded sites outside the continental U.S., sites without a
dermatology clinic, and the 3 sites where the formative evaluation of this study will
be performed (i.e., Providence, RI; San Francisco, CA; and Denver, CO).
We found this trial at
3
sites
Durham, North Carolina 27705
?
mi
from
Durham, NC
Click here to add this to my saved trials
Providence, Rhode Island 02908
?
mi
from
Providence, RI
Click here to add this to my saved trials
San Francisco, California 94121
Principal Investigator: Dennis H. Oh, MD PhD
Phone: 415-750-2091
?
mi
from
San Francisco, CA
Click here to add this to my saved trials